This gene has been consistently identified as a risk locus for breast cancer, and 7 SNPs in FGFR2 have had a reported GWAS p-value less than 10−5 (Easton et al., 2007; Hunter et al., 2007; Gaudet et al., 2010; Elgazzar et al., 2012). This evidence concerns the gene FGFR2 and breast cancer.